Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DNTH
DNTH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DNTH News
Oorja Bio Secures $30 Million Series A Financing for IPF Therapy
May 19 2026
Globenewswire
Oorja Bio Secures $30 Million Series A Financing for IPF Therapy
May 19 2026
Newsfilter
Octagon Capital Reduces Stake in Dianthus Therapeutics
May 18 2026
Fool
Cormorant Asset Management Acquires Dianthus Therapeutics Shares
May 17 2026
Fool
Leads Biolabs Partners with Dianthus to Advance LBL-047 Clinical Development
May 06 2026
Globenewswire
Leads Biolabs Partners with Dianthus to Advance LBL-047 Clinical Development
May 06 2026
Newsfilter
Dianthus Therapeutics Q1 Earnings Beat Expectations
May 05 2026
seekingalpha
Dianthus Grants Equity Awards to New Employees
May 01 2026
Newsfilter
Dianthus Therapeutics CFO Sells Shares for Profit
Apr 19 2026
Fool
Dianthus Therapeutics CFO Sells Shares in Major Transaction
Apr 19 2026
NASDAQ.COM
Dianthus Executive Sells 114,367 Shares for $9.49 Million
Apr 06 2026
Fool
Savitz Sells 114,367 Shares of Dianthus for $9.49 Million
Apr 06 2026
NASDAQ.COM
Dianthus Therapeutics Shares Surge 5.6% on Positive Pipeline News
Apr 01 2026
NASDAQ.COM
Dianthus Therapeutics FDA Approves Clinical Changes for Claseprubart
Mar 26 2026
seekingalpha
5AM Venture Management Fully Exits Dianthus Therapeutics
Mar 18 2026
Fool
Dianthus Therapeutics Hits Early 'Go' in CAPTIVATE Phase 3 CIDP Trial
Mar 15 2026
Yahoo Finance
Show More News
